http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100017494-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aec635d2d60046ad92b0010c89dac506 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4725 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| filingDate | 2008-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a69450ca3b4f4dfbb0a8806febe6866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc3c0e9920c6ad2e92fee942c0465fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ef8bd2dc7f6fd33e5f1e11815dd892 |
| publicationDate | 2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100017494-A |
| titleOfInvention | Treatment of Wounds and Skin Damage with Nucleic Acids Encoding Proteoglycan Polypeptides |
| abstract | The present invention is directed to a nucleic acid structure encoding at least one polypeptide comprising at least one glycosaminoglycan chain, such as (but not limited to) a proteoglycan polypeptide, wherein the polypeptide is glycosylated by the glycosaminoglycan chain. At least one nucleic acid structure encoding the same one or more polypeptides is applied to the wound or skin injury site through the normal physiological process of the subject administered to the wound site to produce a functional proteoglycan polypeptide for the healing of a wound or other skin injury. It is about how to deliver. The delivered nucleic acid structure is transcribed, translated, or post-translationally modified in such a way as to add a glycosaminoglycan chain (referred to herein as "linkage" or "glyciation") to create a linked polypeptide. The linked polypeptide is then secreted in the cell, which is produced in the cell to provide for wound healing and / or skin damage and / or prevention of skin damage in the individual. |
| priorityDate | 2007-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 531.